Skip to main content

Cell-Free RNA Isolation and Extraction Kits Market Size, Global Trends, Latest Techniques, Key Segments And Forecasts Till 2032

Cell-Free RNA Isolation and Extraction Kits Market


 The market for cell-free RNA isolation and extraction kits is substantial and plays a crucial role in the gathering of data for a variety of treatment strategies, underscoring its importance in the healthcare industry. Since it ensures the safe and efficient use of targeted therapies, cell-free RNA is essential to the precision medicine approach. The majority of market participants in the global market for cell-free RNA isolation and extraction kits offer goods that include the kits.

The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032. The growth in the cell-free RNA isolation and extraction kits market is expected to be driven by an increasing number of kits and a rising number of open-source free sequencing platform providers offering cell-free RNA analysis.

Cell-Free RNA Isolation and Extraction Kits Market

Impact

•   The presence of major products of cell-free RNA isolation and extraction kits in regions such as North America and APAC has a major impact on the market. For instance, QIAGEN N.V. provides cell-free RNA isolation and extraction kits.
•   Companies such as Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems The presence of these companies has a positive impact on the market growth.

 

Recent Developments in Global Cell-Free RNA Isolation and Extraction Kits Market

•    In February 2022, Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems.
•    In February 2019, Norgen Biotek Corp. introduced the cf-DNA / cf-RNA Preservative Tubes for long-term storage of blood. These are more suitable blood collection tubes (BCTs) as compared to other competitor’s blood collection tubes (BCTs) in the cell-free RNA market. This is the only product that keeps both cf-DNA and cf-RNA in the same tube for 30 days, allowing researchers to examine both genomics and transcriptomics.

 

Market Segmentation:

Cell-Free RNA Isolation and Extraction Kits Market

Segmentation 1: by Application
•    Oncology
•    Prenatal Screening (Preeclampsia)
•    Metabolic Disorders

The oncology segment accounted for the largest share of 79.85% in the global cell-free RNA isolation and extraction kits market in 2021.

 

Segmentation 2: by End User
•    Hospitals
•    Academic Research Institutions and Laboratories
•    Pharmaceutical and Biotechnology Companies
•    Diagnostic Laboratories

The academic research institutions and laboratories segment accounted for the largest share of 63.13% in the global cell-free RNA isolation and extraction kits market in FY2021.

Segmentation 3: by Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Rest-of-the-World

 

North America cell-free RNA isolation and extraction market dominated the global cell-free RNA isolation and extraction kits market and is expected to maintain its dominance over other regions throughout the forecast period 2022-2032.

Demand – Drivers and Limitations

Following are the demand drivers for the Global Cell-Free RNA Isolation and Extraction Kits Market:

•    Increasing Incidence of Cancer
•    Increasing Number of Cases with Prenatal Complications
•    Advancement in the RNA Sequencing Technology

The market is expected to face some limitations too due to the following challenges:

•    Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods
•    Ethical, Legal, and Social Issues Associated with Prenatal Screening


Get Free Sample Report - https://bisresearch.com/requestsample?id=1355type=download


Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The leading top segment players include cell-free RNA isolation and extraction kits manufacture in year 2021 that caters to different area of application that includes oncology, prenatal screening, and metabolic disorders.

Some of the prominent names established in this market are:

•    Aline Biosciences
•    Apostle Sciences
•    Danagen-Bioted, S.L.
•    F. Hoffmann-La Roche Ltd.
•    JBS Science Inc.
•    Norgen Biotek Corp.
•    PerkinElmer, Inc.
•    Promega Corporation
•    QIAGEN N.V.
•    Streck, Inc.
•    Thermo Fisher Scientific Inc.
•    Takara Bio Inc.
•    Zymo Research Corporation

Key Questions Answered in the Report

  • How is the cell-free RNA isolation and extraction kits
  • market revolutionizing oncology, prenatal screening, and metabolic disorders’ landscapes?
  • What are the major market drivers, challenges, and opportunities in the global cell-free RNA isolation and extraction kits market?
  • What are the underlying structures resulting in the emerging trends within the cell-free RNA isolation and extraction kits market?
  • What are the key development strategies that are being implemented by major players to sustain themselves in the market?
  • What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free RNA products and services?

  USP of this report

• Extensive competitive benchmarking of the top 13 players has been done to offer a holistic view of the global cell-free RNA isolation and extraction kits market landscape 
• Market ranking analysis based on product portfolio, recent developments, and regional spread 
• Investment landscape including product adoption scenario, funding, and patent analysis

BIS Related Studies

Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis

Global Nucleic Acid Isolation and Purification Market

Comments

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p